Free Trial

Ekso Bionics (EKSO) Competitors

$1.10
-0.02 (-1.79%)
(As of 06/7/2024 ET)

EKSO vs. PDYN, AZ, KITT, TAYD, AIMC, SYM, NDSN, RRX, ESAB, and ATS

Should you be buying Ekso Bionics stock or one of its competitors? The main competitors of Ekso Bionics include Palladyne AI (PDYN), A2Z Smart Technologies (AZ), Nauticus Robotics (KITT), Taylor Devices (TAYD), Altra Industrial Motion (AIMC), Symbotic (SYM), Nordson (NDSN), Regal Rexnord (RRX), ESAB (ESAB), and ATS (ATS). These companies are all part of the "general industrial machinery," industry.

Ekso Bionics vs.

Palladyne AI (NASDAQ:PDYN) and Ekso Bionics (NASDAQ:EKSO) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, community ranking, media sentiment, valuation and institutional ownership.

Palladyne AI has a beta of 3.42, suggesting that its stock price is 242% more volatile than the S&P 500. Comparatively, Ekso Bionics has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500.

Ekso Bionics has a net margin of -79.48% compared to Ekso Bionics' net margin of -1,390.02%. Ekso Bionics' return on equity of -74.87% beat Palladyne AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Palladyne AI-1,390.02% -74.87% -57.30%
Ekso Bionics -79.48%-95.36%-46.29%

Ekso Bionics has higher revenue and earnings than Palladyne AI. Ekso Bionics is trading at a lower price-to-earnings ratio than Palladyne AI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Palladyne AI$6.15M7.66-$115.59M-$3.94-0.45
Ekso Bionics$17.91M1.12-$15.20M-$0.97-1.13

In the previous week, Palladyne AI had 2 more articles in the media than Ekso Bionics. MarketBeat recorded 3 mentions for Palladyne AI and 1 mentions for Ekso Bionics. Ekso Bionics' average media sentiment score of 1.00 beat Palladyne AI's score of 0.34 indicating that Palladyne AI is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Palladyne AI
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ekso Bionics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Ekso Bionics received 318 more outperform votes than Palladyne AI when rated by MarketBeat users.

CompanyUnderperformOutperform
Palladyne AIN/AN/A
Ekso BionicsOutperform Votes
318
57.50%
Underperform Votes
235
42.50%

Ekso Bionics has a consensus target price of $10.00, suggesting a potential upside of 809.09%. Given Palladyne AI's higher probable upside, analysts clearly believe Ekso Bionics is more favorable than Palladyne AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Palladyne AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Ekso Bionics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

26.0% of Palladyne AI shares are held by institutional investors. Comparatively, 6.4% of Ekso Bionics shares are held by institutional investors. 12.0% of Palladyne AI shares are held by company insiders. Comparatively, 6.1% of Ekso Bionics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Palladyne AI and Ekso Bionics tied by winning 8 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EKSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EKSO vs. The Competition

MetricEkso BionicsGeneral industrial machinery, IndustryMedical SectorNASDAQ Exchange
Market Cap$19.99M$3.71B$5.22B$8.20B
Dividend YieldN/A0.82%2.73%4.04%
P/E Ratio-1.136.62120.0414.65
Price / Sales1.124.852,432.4578.07
Price / CashN/A15.6835.2531.17
Price / Book1.293.784.964.32
Net Income-$15.20M$9.43M$110.34M$216.21M
7 Day Performance-4.35%-2.19%-1.05%-1.43%
1 Month Performance-20.29%-3.87%-0.61%-0.59%
1 Year Performance-19.71%-1.06%2.92%3.58%

Ekso Bionics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDYN
Palladyne AI
0 of 5 stars
$1.77
+0.6%
N/AN/A$46.82M$6.15M-0.4570Positive News
AZ
A2Z Smart Technologies
0 of 5 stars
$0.39
-2.5%
N/A-81.2%$16.07M$11.38M-1.18201News Coverage
Gap Up
KITT
Nauticus Robotics
0 of 5 stars
$0.16
-11.4%
N/A-92.2%$9.68M$6.61M-0.1272Gap Up
High Trading Volume
TAYD
Taylor Devices
0 of 5 stars
$46.92
-2.3%
N/A+150.0%$169.03M$40.20M18.84125
AIMC
Altra Industrial Motion
0 of 5 stars
$61.98
flat
N/AN/A$4.05B$1.95B31.959,300Analyst Forecast
SYM
Symbotic
2.6489 of 5 stars
$36.79
-6.5%
$55.69
+51.4%
-8.6%$23.01B$1.18B-153.291,300High Trading Volume
NDSN
Nordson
4.2663 of 5 stars
$226.15
-0.2%
$277.83
+22.9%
-3.1%$12.97B$2.63B26.957,900Positive News
RRX
Regal Rexnord
4.6668 of 5 stars
$141.33
+0.8%
$192.00
+35.9%
-4.1%$9.32B$6.25B-294.4432,100Analyst Forecast
News Coverage
ESAB
ESAB
1.4458 of 5 stars
$93.35
-1.0%
$96.29
+3.1%
+43.2%$5.64B$2.77B24.449,000Positive News
ATS
ATS
2.5599 of 5 stars
$32.84
+0.1%
$45.67
+39.1%
-26.4%$3.22B$2.29B22.497,000Positive News

Related Companies and Tools

This page (NASDAQ:EKSO) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners